Bernstein analyst Florent Cespedes maintained a Buy rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £22.90. The company’s shares opened today at p1,443. ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback